title: [Use of Navoban in pediatric oncology].
abstract: In the course of treatment for tumors and recurrences, 86 children, aged 4-16 years, received polychemotherapy which induced excessive vomiting. Navoban (tropisetron) was administered to control vomiting. Total or partial control of nausea and vomiting was observed in 94.1%. No side-effects were registered.
authors.forename: S A
authors.initials: SA
authors.lastname: Safonova
authors.forename: B A
authors.initials: BA
authors.lastname: Kolygin
authors.forename: I A
authors.initials: IA
authors.lastname: Punanov
authors.forename: A F
authors.initials: AF
authors.lastname: Borodina
mesh_terms: D000293:Adolescent; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome; D000077526:Tropisetron; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D007211:Indoles; D000077526:Tropisetron